LaFerla FM, Green KN, Oddo S. Intracellular amyloid-beta in Alzheimer’s disease. Nat Rev Neurosci. 2007;8:499–509.

Article  CAS  PubMed  Google Scholar 

Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci U S A. 1985;82:4245–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, et al. Lecanemab in Early Alzheimer’s Disease. N Engl J Med. 2023;388:9–21.

Article  PubMed  Google Scholar 

Weglinski C, Jeans A. Amyloid-β in Alzheimer’s disease - front and centre after all? Neuronal Signal. 2023;7:NS20220086.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hawksworth J, Fernández E, Gevaert K. A new generation of AD biomarkers: 2019 to 2021. Ageing Res Rev. 2022;79:101654.

Article  CAS  PubMed  Google Scholar 

Kepp KP, Robakis NK, Høilund-Carlsen PF, Sensi SL, Vissel B. The amyloid cascade hypothesis: an updated critical review. Brain [Internet]. 2023; https://doi.org/10.1093/brain/awad159.

Sims JR, Zimmer JA, Evans CD, Lu M, Ardayfio P, Sparks J et al. Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial. JAMA [Internet]. 2023; https://doi.org/10.1001/jama.2023.13239.

Chow VW, Mattson MP, Wong PC, Gleichmann M. An overview of APP processing enzymes and products. Neuromolecular Med. 2010;12:1–12.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Walsh DM, Selkoe DJ. A critical appraisal of the pathogenic protein spread hypothesis of neurodegeneration. Nat Rev Neurosci. 2016;17:251–60.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xiao Y, Ma B, McElheny D, Parthasarathy S, Long F, Hoshi M, et al. Aβ(1–42) fibril structure illuminates self-recognition and replication of amyloid in Alzheimer’s disease. Nat Struct Mol Biol. 2015;22:499–505.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Törnquist M, Cukalevski R, Weininger U, Meisl G, Knowles TPJ, Leiding T, et al. Ultrastructural evidence for self-replication of Alzheimer-associated Aβ42 amyloid along the sides of fibrils. Proc Natl Acad Sci U S A. 2020;117:11265–73.

Article  PubMed  PubMed Central  Google Scholar 

Wu Y-S, Huang S-J, Wu M-H, Tu L-H, Lee M-C, Chan JCC. Aβ 42 oligomers can seed the fibrillization of Aβ 40 peptides. J Chin Chem Soc. 2022;69:1318–25.

Article  CAS  Google Scholar 

Walker LC, Schelle J, Jucker M. The Prion-Like Properties of Amyloid-β Assemblies: Implications for Alzheimer’s Disease. Cold Spring Harb Perspect Med [Internet]. 2016;6. https://doi.org/10.1101/cshperspect.a024398.

Watts JC, Prusiner SB. β-Amyloid Prions and the Pathobiology of Alzheimer’s Disease [Internet]. Cold Spring Harbor Perspectives in Medicine. 2018. p. a023507. https://doi.org/10.1101/cshperspect.a023507.

Condello C, Merz GE, Aoyagi A, DeGrado WF, Prusiner SB. Aβ and tau prions causing Alzheimer’s Disease. Methods Mol Biol. 2023;2561:293–337.

Article  CAS  PubMed  Google Scholar 

Carlson GA, Prusiner SB. How an Infection of Sheep Revealed Prion Mechanisms in Alzheimer’s Disease and Other Neurodegenerative Disorders. Int J Mol Sci [Internet]. 2021;22. https://doi.org/10.3390/ijms22094861.

Watts JC, Condello C, Stöhr J, Oehler A, Lee J, DeArmond SJ, et al. Serial propagation of distinct strains of Aβ prions from Alzheimer’s disease patients. Proc Natl Acad Sci U S A. 2014;111:10323–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jaunmuktane Z, Mead S, Ellis M, Wadsworth JDF, Nicoll AJ, Kenny J, et al. Evidence for human transmission of amyloid-β pathology and cerebral amyloid angiopathy. Nature. 2015;525:247–50.

Article  CAS  PubMed  Google Scholar 

Purro SA, Farrow MA, Linehan J, Nazari T, Thomas DX, Chen Z, et al. Transmission of amyloid-β protein pathology from cadaveric pituitary growth hormone. Nature. 2018;564:415–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Banerjee G, Samra K, Adams ME, Jaunmuktane Z, Parry-Jones AR, Grieve J et al. Iatrogenic cerebral amyloid angiopathy: an emerging clinical phenomenon. J Neurol Neurosurg Psychiatry [Internet]. 2022; https://doi.org/10.1136/jnnp-2022-328792.

Meyer-Luehmann M, Coomaraswamy J, Bolmont T, Kaeser S, Schaefer C, Kilger E, et al. Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host. Science. 2006;313:1781–4.

Article  CAS  PubMed  Google Scholar 

Gary C, Lam S, Hérard A-S, Koch JE, Petit F, Gipchtein P, et al. Encephalopathy induced by Alzheimer brain inoculation in a non-human primate. Acta Neuropathol Commun. 2019;7:126.

Article  PubMed  PubMed Central  Google Scholar 

Lim CH, Kaur P, Teo E, Lam VYM, Zhu F, Kibat C et al. Application of optogenetic Amyloid-β distinguishes between metabolic and physical damages in neurodegeneration. Elife [Internet]. 2020;9. https://doi.org/10.7554/eLife.52589.

Lam S, Petit F, Hérard A-S, Boluda S, Eddarkaoui S, Guillermier M, et al. Transmission of amyloid-beta and tau pathologies is associated with cognitive impairments in a primate. Acta Neuropathol Commun. 2021;9:165.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Steffen J, Krohn M, Schwitlick C, Brüning T, Paarmann K, Pietrzik CU, et al. Expression of endogenous mouse APP modulates β-amyloid deposition in hAPP-transgenic mice. Acta Neuropathol Commun. 2017;5:49.

Article  PubMed  PubMed Central  Google Scholar 

Baker HF, Ridley RM, Duchen LW, Crow TJ, Bruton CJ. Evidence for the experimental transmission of cerebral beta-amyloidosis to primates. Int J Exp Pathol. 1993;74:441–54.

CAS  PubMed  PubMed Central  Google Scholar 

Maclean CJ, Baker HF, Ridley RM, Mori H. Naturally occurring and experimentally induced beta-amyloid deposits in the brains of marmosets (Callithrix jacchus). J Neural Transm. 2000;107:799–814.

Article  CAS  PubMed  Google Scholar 

Ridley RM, Baker HF, Windle CP, Cummings RM. Very long term studies of the seeding of beta-amyloidosis in primates. J Neural Transm. 2006;113:1243–51.

Article  CAS  PubMed  Google Scholar 

Bornemann KD, Staufenbiel M. Transgenic mouse models of Alzheimer’s disease. Ann N Y Acad Sci. 2000;908:260–6.

Article  CAS  PubMed  Google Scholar 

Sturchler-Pierrat C, Staufenbiel M. Pathogenic mechanisms of Alzheimer’s disease analyzed in the APP23 transgenic mouse model. Ann N Y Acad Sci. 2000;920:134–9.

Article  CAS  PubMed  Google Scholar 

Nery LR, Eltz NS, Hackman C, Fonseca R, Altenhofen S, Guerra HN, et al. Brain intraventricular injection of amyloid-β in zebrafish embryo impairs cognition and increases tau phosphorylation, effects reversed by lithium. PLoS ONE. 2014;9:e105862.

Article  PubMed  PubMed Central  Google Scholar 

Bhattarai P, Thomas AK, Zhang Y, Kizil C. The effects of aging on Amyloid-β42-induced neurodegeneration and regeneration in adult zebrafish brain. Neurogenesis (Austin). 2017;4:e1322666.

Article  PubMed  Google Scholar 

Saleem S, Kannan RR. Zebrafish: an emerging real-time model system to study Alzheimer’s disease and neurospecific drug discovery [Internet]. Cell Death Discovery. 2018. https://doi.org/10.1038/s41420-018-0109-7.

Javed I, Peng G, Xing Y, Yu T, Zhao M, Kakinen A, et al. Inhibition of amyloid beta toxicity in zebrafish with a chaperone-gold nanoparticle dual strategy. Nat Commun. 2019;10:3780.

Article  PubMed  PubMed Central  Google Scholar 

Collinge J. Human prion diseases and bovine spongiform encephalopathy (BSE) [Internet]. Human Molecular Genetics. 1997. pp. 1699–705. https://doi.org/10.1093/hmg/6.10.1699.

Kong Q, Zheng M, Casalone C, Qing L, Huang S, Chakraborty B, et al. Evaluation of the human transmission risk of an atypical bovine spongiform encephalopathy prion strain. J Virol. 2008;82:3697–701.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lee J, Kim SY, Hwang KJ, Ju YR, Woo H-J. Prion Diseases as Transmissible Zoonotic Diseases [Internet]. Osong Public Health and Research Perspectives. 2013. pp. 57–66.